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Objective: To investigate the correlation between JNK signal and the apoptosis of
VSMC as well as the expression of Cathepsin B and to explore the role of JNK signal in
the development of cerebral aneurysm.
Methods: Rat models of cerebral aneurysm were established and histopathologic
changes of cerebral aneurysm and the apoptosis of VSMC were analyzed. Rat models
were respectively subject to subcutaneous injection of Cathepsin B siRNA and JNK
inhibitor SP600125. Western blot technique was used to detect the expression of proteins
like Cathepsin B, Caspase-3, and p-JNK. Spearman's rho was used to examine the cor-
relation between p-JNK and Cathepsin B, as well as the expression of relevant proteins.
Results: The success rate of modeling rats with cerebral aneurysm was 88.75%. After the
respective injection of Cathepsin B siRNA, SP600125 and their combination, the cell
densities of VSMC of rats with cerebral aneurysm all increased signiﬁcantly (P < 0.05 or
P < 0.01), but the apoptosis rate of VSMC decreased signiﬁcantly (P < 0.01). Compared
with normal rats, the expression of Cathepsin B, Caspase-3 and p-JNK in Cerebral
aneurysm models increased signiﬁcantly. Effectively intervening Cathepsin B genes with
Cathepsin B siRNA could signiﬁcantly inhibit the expression of Cathepsin B and Caspase-
3, but hardly inﬂuence the expression of p-JNK. JNK inhibitor SP600125 had no inﬂuence
on the expression of Cathepsin B and Caspase-3, but effectively inhibited the expression
of p-JNK. In cerebral aneurysm tissues, positive correlation was observed between the
expression of p-JNK and Cathepsin B, the correlation coefﬁcient was r = 0.640.
Conclusion: After the attack of cerebral aneurysm, proteins like Cathepsin B, Caspase-3
and p-JNK are all involved in the apoptosis of VSMCs. This process may be realized by
Cathepsin B which activates the apoptosis mechanism of Caspase-3 and mediate the
apoptosis of VSMC through the JNK signaling pathway. Therefore, silencing Cathepsin
B gene or inhibiting the conduction through JNK signaling pathway can mitigate the
apoptosis of vascular smooth muscle cells in cerebral aneurysm.1. Introduction
Cerebral aneurysm is a common cerebrovascular disorder
and its rupture usually leads to high rate of disability and/or
death [1]. Regarding the pathogenesis of cerebral aneurysm,
current studies mainly focus on genetic factors, hemodynamicfactors, and acquired degenerative changes in arterial walls [2–
4]. However, it's also signiﬁcant to explore an effective way to
intervene the growth of cerebral aneurysm by studying its
pathogenesis from the perspective of molecular biology.
Normally, the proliferation and apoptosis of VSMC help to
maintain the balance and stability in blood vessels. However,
the occurrence of cerebral aneurysm breaks such balance,
causing the apoptosis of a large number of VSMCs, as a result
of which weakened walls of blood vessels in the brain fail to
sustain the impact of blood ﬂow [5]. Previous study showed
that excessive apoptosis of VSMC is an important mechanism
for the formation of cerebral aneurysm [6].
Cathepsins are enzymes in lysosomes, including Cathepsin
B, C, K, L, and S and others which play a vital role in theunder the CC BY-NC-ND license (http://
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tease. A wide range of diseases results in elevated levels of
Cathepsin B, which causes pathological processes of numerous
diseases like cancer, inﬂammation, and degenerative diseases.
The inﬂuence of Cathepsin B on apoptosis has also been widely
studied [7]. Caspase-3 is the most critical protease in cell
apoptosis and an activator of the execution-phase of cell
apoptosis [8]. c-Jun N-terminal kinases (JNKs) belong to the
mitogen-activated protein kinase family (MAPK) and JNK
signaling pathways play a vital role in a variety of physiological
processes like cell differentiation, apoptosis and stress [9].
Phosphorylated JNKs (p-JNK) eventually cause a series of
certain biological effects by regulating downstream signaling
molecules. SP600125, an inhibitor of JNKs, can effectively
inhibit the conduction of JNK signaling pathways [10]. By
establishing the mouse model of cerebral aneurysm, this study
explored the apoptosis rate of VSMC and changes in the
expression of Cathepsin B, Caspase-3 and p-JNK. This study
also analyzed the inﬂuence on cerebral aneurysm by effectively
intervening Cathepsin B or blocking JNK signaling pathways in
order to ﬁnd out the role of Cathepsin B and JNK signals in the
pathogenesis of cerebral aneurysm.
2. Material and methods
2.1. Establishment of the rat model of cerebral
aneurysm
A total of 80 male Sprague–Dawley rats, 5–7 weeks old,
provided by Laboratory Animal Center of Zhengzhou University,
were anesthetized by intraperitoneal injection of 3% pentobar-
bital sodium (40 mg/kg). Subsequently, the rats were subjected to
the ligation of left common carotid artery and the bipolar coag-
ulation of posterior branches of bilateral renal arteries. One week
after the procedures, the rats were fed with 1% saline instead of
water until the 12th week. The cerebral vessel wall tissues were
separated from the right ACA-OA under the microscope, ﬁxed
with 4% paraformaldehyde in 0.1 M PBS for 24–48 h, subject to
parafﬁn embedding, sectioning, and hematoxylin-eosin staining.
Finally, histopathologic changes were observed. TUNEL assay
was used to detect the cell density and apoptosis rate of VSMC.
This experiment has been approved by Laboratory Animal Ethics
Committee of Zhengzhou University.
2.2. Grouping and treatment of experimental animals
A total of 50 rat models of cerebral aneurysm were equally
divided into 5 groups, namely the scramble siRNA group subject
to subcutaneous injection of Scramble siRNA, the Cathepsin B
siRNA group subject to subcutaneous injection of Cathepsin B
siRNA, the SP600125 group subject to subcutaneous injection
of SP600125, the Cathepsin B siRNA + SP600125 group subject
to subcutaneous injection of Cathepsin B siRNA + SP600125,
and the model control group subject to subcutaneous injection of
equivalent normal saline.
2.3. TUNEL assay used to detect the cell density and
apoptosis rate of VSMC
Deparafﬁn cerebral vessel wall tissues of all groups with
dimethylbenzene and ethanol till all the parafﬁn was replaced bywater. Use Proteinase K to digest the tissues at room tempera-
ture, use 3% H2O2 in methanol to block the activity of endog-
enous horseradish peroxidase, add TdT and digoxin-labeled
dUTP for mixture reaction, incubate the tissues, add horseradish
peroxidase-labeled anti-digoxin antibody for incubation, use
DAB-H2O2 solution to stain. Cells with dark brown nuclei were
in the process of apoptosis. Finally, restain, dehydrate, clear, and
mount the tissues. For negative control groups, replace TdT
solution with PBS buffer. Count the number of cells in certain
visual ﬁelds under 400X microscope, calculate cell density.
Given 200 cells in each visual ﬁeld, calculate the percentage of
cells in apoptosis, namely cell apoptosis rate.
2.4. Western blotting
Extract the total protein of tissues of all groups, use 50 mg
protein for 15% SDS-PAGE, then transfer proteins to PVDF
membrane, use 5% nonfat milk in TBST buffer as a blocking
agent, incubate overnight at 4 C respectively with Cathepsin B
rat anti-human polyclonal antibody (1:200), Caspase-3 rabbit
anti-human polyclonal antibody (1:300), rat anti-human p-JNK
monoclonal antibody (1:400), and b-actin rat anti-human
monoclonal antibody (1:200), then incubate with HRP-labeled
goat anti-rat second antibody (1:500) at 37 C for 1 h, rinse
the membrane with TBST, then use electrochemical lumines-
cence (ECL) assay to observe the results. All antibodies were
bought from Santa Cruz Biotechnology Inc. The same method
was used to detect the expression of p-JNK and Cathepsin B in
the other 21 cerebral aneurysm rat models.
2.5. Statistical analysis
Software SPSSl7.0 was used for One-way ANOVA of rele-
vant data. Spearman's rho was used to analyze the correlations
between the expression of p-JNK and Cathepsin B. All the data
were represented with Mean ± SD. A value of P < 0.05 was
considered statistically signiﬁcant.
3. Results
3.1. Establishment of the rat model of cerebral
aneurysm
Under light microscope, 30 of 71 rats have aneurysm-like
lesions, all of which were at the intersection of anterior cere-
bral artery-olfactory artery (ACA-OA) on the contralateral side
of the circle of Willis with the success rate of modeling being
88.75%. HE staining showed that normal arteries had complete
endothelial cells and smooth muscle ﬁbers and tunica adventitia
were neat and compact, while in cerebral aneurysm arteries
collagenous ﬁbers of cerebral aneurysm thickened, smooth
muscle layer atrophied, tunica adventitia was loose, and there
was thrombosis at the lumen of the aneurysm.
3.2. Detecting the cell density and apoptosis rate of
VSMC
In Situ cell death detection with TUNEL assay showed
that compared with the model control group, VSMC cell den-
sities of the Cathepsin B siRNA group, the SP600125 group,
and the Cathepsin B siRNA + SP600125 group all increased
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compared with that of normal rats (P < 0.01). Compared with
normal rats, the VSMC apoptosis rate of the cerebral aneurysm
model control group increased signiﬁcantly (P < 0.01).
Compared with the cerebral aneurysm model control group,
VSMC apoptosis rates of the Cathepsin B siRNA group, the
SP600125 group, and the Cathepsin B siRNA + SP600125
group decreased signiﬁcantly (P < 0.01), but were all higher
than that of normal rats (P < 0.01) (Table 1).
3.3. Detecting the expression of relevant proteins
There was weak or no expression of Cathepsin B in the tis-
sues of cerebral vessel wall of normal rats, but signiﬁcantly
increased expression of Cathepsin B was observed in cerebral
aneurysm models. Effectively intervening Cathepsin B genes
with Cathepsin B siRNA could obviously inhibit the expression
of relevant proteins. However, JNK inhibitor SP600125 had no
inﬂuence on the expression of Cathepsin B. Caspase-3 was
expressed in normal tissues, but cerebral aneurysm caused
signiﬁcantly higher expression level of Caspase-3. The expres-
sion of Caspase-3 in cerebral aneurysm models was inhibited by
the injection of Cathepsin B siRNA, but not inﬂuenced by the
injection of JNK inhibitor SP600125. p-JNK was expressed in
normal tissues, but more signiﬁcantly expressed in cerebral
aneurysm tissues. Cathepsin B siRNA had no signiﬁcant inﬂu-
ence on the expression of Cathepsin B; however, JKN inhibitor
SP600125 effectively inhibited the expression of p-JNK
(Table 2).
3.4. Correlation between the expression of p-JNK and
Cathepsin B
The expression of p-JNK and Cathepsin B in cerebral
aneurysm models subject to no treatment was respectively
examined. Spearman's rho was used to analyze the correlationTable 1
Cell density and apoptosis rate of VSMC.
Group Cell density (SMCs/HPF) Apoptosis rate (%)
Normal control 225.84 ± 11.02 3.23 ± 0.06
Model control 37.96 ± 2.01*# 31.05 ± 1.04**
Scramble siRNA 40.21 ± 2.54** 28.66 ± 0.87**
Cathepsin B siRNA 68.76 ± 3.01**# 17.09 ± 2.41**#
SP600125 72.05 ± 5.46**# 15.87 ± 1.77**#
Cathepsin B
siRNA + SP600125
123.36 ± 10.12**# 9.52 ± 1.48**#
*P < 0.05, **P < 0.01 vs. normal control group.
#P < 0.05 vs. model control group.
Table 2
Relative expression of Cathepsin B, Caspase-3 and p-JNK.
Group Cathepsin B Caspase-3 p-JNK
Normal control 0.085 ± 0.02 0.354 ± 0.11 0.202 ± 0.06
Model control 0.539 ± 0.21** 0.764 ± 0.18** 0.498 ± 0.13*
Scramble siRNA 0.519 ± 0.14** 0.805 ± 0.25** 0.487 ± 0.08*
Cathepsin B siRNA 0.032 ± 0.01## 0.148 ± 0.09*## 0.492 ± 0.22*
SP600125 0.535 ± 0.23** 0.771 ± 0.32** 0.056 ± 0.01**#
Cathepsin B
siRNA + SP600125
0.041 ± 0.05## 0.057 ± 0.03**# 0.037 ± 0.05**#
*P < 0.05, **P < 0.01 vs. normal control group.
#P < 0.05, ##P < 0.05 vs. model control group.between the expressions of them. Positive correlation was
observed between the expression of p-JNK and Cathepsin B, the
correlation coefﬁcient was r = 0.640, P = 0.002. According to
the ﬁtting degree of the trend line, the coefﬁcient of determi-
nation (R2) = 0.589.
4. Discussions
The incidence of 2%–3% of cerebral aneurysm leads to an
annual incidence of 0.6‰–2‰ of subarachnoid hemorrhage
(SAH) [11,12]. Endothelial dysfunction is the initial symptom of
cerebral aneurysm, followed by the phenotypic modulation of
VSMCs, extracellular matrix remodeling, the apoptosis of
VSMC and the degeneration, expansion and rupture of the
vessel wall [13]. However, the speciﬁc pathogenesis remains
unclear. This study investigated the role of Cathepsin B,
Caspase-3 and JNK signaling pathway, which are closely
related to cell apoptosis, in the attack and development of ce-
rebral aneurysm from the perspective of molecular biology.
Normally, Cathepsin B lies in lysosomes and is involved in
physiological processes, like the growth of the body. However,
when the cellular injury leads to increased permeability of
lysosome membrane or even the rupture of lysosome membrane,
Cathepsin B will enter the cytoplasm or surrounding tissues, be
activated and mediate inﬂammatory necrosis and apoptosis of
cells [14,15]. Experimental results showed that the expression of
Cathepsin B and Caspase-3 was signiﬁcantly higher in cere-
bral aneurysm rat models than in normal rats, and the injected
siRNA inhibited not only the expression of Cathepsin B but also
that of Caspase-3. This suggests that during the attack of cere-
bral aneurysm, Cathepsin B may cause the apoptosis of cells by
activating Caspase-3. However, no ﬁnal conclusion has yet been
reached on the speciﬁc mechanism of Cathepsin B activating
Caspase-3. Some research has shown that Cathepsin B can
directly catalyze Caspase precursor to activate it thus causing
cell apoptosis [16]. Some studies conclude that Cathepsin B
indirectly activates Caspase, ﬁrstly by triggering
mitochondrion through Bid to release cytochrome c, then
activating Caspase family to cause apoptosis [17,18]. However,
both approaches ﬁnally work on Caspase-3, the effector of
apoptosis, which cause apoptosis together with the apoptosis
substrate. Tsubokawa et al. [19] found that in the rat model of
ischemia-reperfusion injury, the expression of Cathepsin B in
the ischemic cortex increased and caused an increased expres-
sion of Caspase-3 via bcl-2 family members, thus inﬂuencing the
apoptosis of neurocytes. Moreover, some study found that the
expression of Cathepsin B during the apoptosis of neurocytes in
the rat model of ischemia-reperfusion injury increased and it
inﬂuenced the apoptosis of neurons through signaling pathway
or other ways [20].
According to results of this study, in cerebral aneurysm tis-
sues, the expression of p-JNK and Cathepsin B both increased
signiﬁcantly and positive correlation was observed. However,
Cathepsin B siRNA had no inﬂuence on the expression of p-
JNK, neither did JNK inhibitor SP600125 on the expression of
Cathepsin B. The speciﬁc correlation between Cathepsin B and
JNK signaling pathway has not being clear yet. There is a
research proving that JNK signaling pathway is an important
pro-apoptotic pathway [21]. However, Cathepsin B is involved in
cell apoptosis in a quite complicated way. It may mediate the
apoptosis either through one protein or certain signaling
pathway [22,23]. Therefore, we conclude that in cerebral
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smooth muscle cells through JNK signaling pathway.
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